Edex (Endo Pharmaceuticals) – sterility concern (2017)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in Germany for: Actient Pharmaceuticals, LLC, Lake Forest, Illinois 60045; NDC 52244-010-02.
Brand
Endo Pharmaceuticals, Inc.
Lot Codes / Batch Numbers
Lot #: 207386, Exp. May 2019
Products Sold
Lot #: 207386, Exp. May 2019
Endo Pharmaceuticals, Inc. is recalling Edex (alprostadil for injection) 10mcg, packaged in a 2 pack carton, Rx only, Manufactured in German due to Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026